We are live on ! Find out more
ACM

Accent Capital Management Portfolio holdings

AUM $206M
1-Year Est. Return 29.56%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+29.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$26.4M
Cap. Flow
-$7.39M
Cap. Flow %
-3.58%
Top 10 Hldgs %
69.38%
Holding
412
New
65
Increased
63
Reduced
65
Closed
78

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$95.3K
2
ASML icon
ASML
ASML
+$78.1K
3
AZN icon
AstraZeneca
AZN
+$78.1K
4
VTI icon
Vanguard Total Stock Market ETF
VTI
+$72.8K
5
NVS icon
Novartis
NVS
+$69.6K

Sector Composition

Rank Sector Weight
1 Technology 36.33%
2 Communication Services 18.36%
3 Consumer Discretionary 11.2%
4 Financials 8.78%
5 Consumer Staples 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
76
Stryker
SYK
$127B
$65.9K 0.03%
200
BABA icon
77
Alibaba
BABA
$269B
$63.7K 0.03%
508
-1,183
-70% -$178K
CASY icon
78
Casey's General Stores
CASY
$31.9B
$63.3K 0.03%
87
+51
+142% +$33.2K
ATE
79
DELISTED
Advantest Corp
ATE
$63K 0.03%
+464
New +$63K
NKE icon
80
Nike
NKE
$61.9B
$59.4K 0.03%
1,116
ORCL icon
81
Oracle
ORCL
$331B
$58.8K 0.03%
400
-200
-33% -$32.5K
AMD icon
82
Advanced Micro Devices
AMD
$851B
$58.6K 0.03%
288
+195
+210% +$41.6K
FCX icon
83
Freeport-McMoran
FCX
$90B
$54.4K 0.03%
842
+477
+131% +$28.8K
CAT icon
84
Caterpillar
CAT
$409B
$53.8K 0.03%
76
+39
+105% +$27K
GBIO
85
DELISTED
Generation Bio
GBIO
$53.3K 0.03%
61
+35
+135% +$195
COR icon
86
Cencora
COR
$60.3B
$52.5K 0.03%
167
+54
+48% +$18.9K
MRK icon
87
Merck
MRK
$324B
$50.9K 0.02%
420
NFLX icon
88
Netflix
NFLX
$292B
$47.1K 0.02%
490
C icon
89
Citigroup
C
$222B
$46.7K 0.02%
412
MCD icon
90
McDonald's
MCD
$188B
$46.6K 0.02%
150
COP icon
91
ConocoPhillips
COP
$147B
$45K 0.02%
341
+246
+259% +$27.2K
IHE icon
92
iShares US Pharmaceuticals ETF
IHE
$1.47B
$43.3K 0.02%
500
VNT icon
93
Vontier
VNT
$4.33B
$43.3K 0.02%
1,220
+610
+100% +$23.5K
GSK icon
94
GSK
GSK
$103B
$43.1K 0.02%
+781
New +$42.3K
RTO icon
95
Rentokil
RTO
$14.3B
$43K 0.02%
1,366
+703
+106% +$22.1K
PBR icon
96
Petrobras
PBR
$121B
$42.4K 0.02%
+2,044
New +$32.7K
CNQ icon
97
Canadian Natural Resources
CNQ
$96.9B
$42.3K 0.02%
+869
New +$35.7K
SCCO icon
98
Southern Copper
SCCO
$141B
$42K 0.02%
246
+165
+204% +$30.2K
TMO icon
99
Thermo Fisher Scientific
TMO
$211B
$38.8K 0.02%
79
+54
+216% +$29.3K
MDGL icon
100
Madrigal Pharmaceuticals
MDGL
$12.6B
$36.6K 0.02%
70
-24
-26% -$11.5K

Similar funds

Accent Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Accent Capital Management held 412 positions worth $206M, down 11% from $233M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Accent Capital Management withdrew a net $7.39M in Q1 2026, closing 78 positions and reducing 65 holdings. Its most notable exit was UnitedHealth, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Accent Capital Management opened a new position in Novartis worth $69.3K.

  • Accent Capital Management's largest Q1 2026 buy was Novartis: 454 shares worth $69.3K.
  • Accent Capital Management added most to TSMC in Q1 2026, an estimated $95.3K increase.
  • Accent Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $1.37M.
  • Accent Capital Management fully exited UnitedHealth in Q1 2026, selling an estimated $2.17M.
  • Accent Capital Management's ten largest holdings make up 69% of its $206M portfolio in Q1 2026.
  • Accent Capital Management opened 65 new positions and closed 78 in Q1 2026.
  • Accent Capital Management's portfolio value fell 11% quarter-over-quarter to $206M.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.